The world of prescription drug care and coverage can be complicated. Read AMCP CEO Susan Cantrell’s blog on AMCP’s inaugural “Access, Affordability, & Outcomes: The Value of Managed Care Pharmacy” annual report to learn how we’re making it more understandable
On Aug. 30, 2023, the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury issued the proposed rule titled “Requirements Related to the Mental Health Parity and Addiction Equity Act. AMCP submitted comments in response to the proposed rule on Oct. 17.
With October devoted to National Pharmacy Awareness, AMCP CEO Susan Cantrell talks about the outstanding efforts of managed care pharmacists across the United States in her latest blog.
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.
September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
On August 21, 2023, CMS Issued the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025. The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program.
From volunteering for the Education Affairs Committee to serving as an AMCP Diplomat, Teresa Roane has become a vital member in pushing AMCP's mission forward. Learn more about her experience in the AMCP Volunteer Spotlight.